GL1X · GenesisL1 explorer

MolNFT v1 · #162919 · protein

RIP2 kinase catalytic domain complex with 2({4[(1,3BENZOTHIAZOL5YL) AMINO]6(2METHYLPROPANE2SULFONYL)QUINAZOLIN7YL}OXY)ETHAN1OL

6RNA · Receptor-interacting SERINE/THREONINE-protein kinase 2: “RIP2 kinase catalytic domain complex with 2({4[(1,3BENZOTHIAZOL5YL)…”. X-ray diffraction, 1 ligand (KA2), 6 pockets (best druggability 0.82). MolNFT v1 #162919 on GenesisL1…

PDB
6RNA
Type
protein
Length
561 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-interacting SERINE/THREONINE-protein kinase 2
EC
2.7.11.1, 2.7.10.2
UniProt
O43353
Ligands
KA2
Pockets
6 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein27740% helix, 18% strandO43353
BReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein28440% helix, 17% strandO43353

Ligands and binding sites

  • KA2 · 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethanol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111230.820.8388empty
22260.620.8230KA2
32650.600.7931KA2
41100.460.7925empty
5620.390.8017empty

Interfaces

1 interface between chains.

  • A–B · 1940 Ų buried · 23 hydrogen bonds · protein-protein

Compared structures

  • 6RNA · RIP2 Kinase Catalytic Domain complex with 2({4[(1,3benzothiazol5yl)amino]6(2methylpropane2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.